Enrique Reyes-Muñoz
Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques—A Literature Review
Reyes-Muñoz, Enrique; Sathyapalan, Thozhukat; Rossetti, Paola; Shah, Mohsin; Long, Min; Buscema, Massimo; Valenti, Gaetano; La Rosa, Valentina Lucia; Cianci, Stefano; Vitale, Salvatore Giovanni
Authors
Professor Thozhukat Sathyapalan T.Sathyapalan@hull.ac.uk
Professor of Diabetes, Endocrinology and Metabolism
Paola Rossetti
Mohsin Shah
Min Long
Massimo Buscema
Gaetano Valenti
Valentina Lucia La Rosa
Stefano Cianci
Salvatore Giovanni Vitale
Abstract
Polycystic ovary syndrome (PCOS) affects 6–10% of women and could be considered one of the most common endocrine alterations in women of reproductive age. The syndrome is characterized by several hormonal and metabolic alterations, including insulin resistance and hyperandrogenism, which play a severe detrimental role in the patient’s fertility. We aimed to offer an overview about drug metabolism in the PCOS population. Nevertheless, we did not find any study that directly compared drug metabolism between PCOS and healthy women. We therefore decided to summarize briefly how hormonal and insulin sensitizer drugs act differently in healthy and PCOS women, who show altered steroidogenesis by theca cells and metabolic imbalance, focusing especially on assisted reproductive techniques. To date, data about drug metabolism in the PCOS population appears to be extremely limited. This important gap could have significant implications for therapeutic approaches and future perspectives: the dosage of drugs commonly used for the treatment of PCOS women should be tailored according to each patient’s characteristics; we should implement new clinical trials in order to identify the best pharmacologic strategy for PCOS patients undergoing in vitro fertilization (IVF); it would be advisable to create an international expert panel to investigate the drug metabolism in the PCOS population.
Citation
Reyes-Muñoz, E., Sathyapalan, T., Rossetti, P., Shah, M., Long, M., Buscema, M., …Vitale, S. G. (2018). Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques—A Literature Review. Advances in Therapy, 35(11), 1805-1815. https://doi.org/10.1007/s12325-018-0810-1
Journal Article Type | Review |
---|---|
Acceptance Date | Oct 4, 2018 |
Online Publication Date | Oct 11, 2018 |
Publication Date | Nov 1, 2018 |
Deposit Date | Oct 13, 2018 |
Publicly Available Date | Oct 15, 2018 |
Journal | Advances in Therapy |
Print ISSN | 0741-238X |
Electronic ISSN | 1865-8652 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 35 |
Issue | 11 |
Pages | 1805-1815 |
DOI | https://doi.org/10.1007/s12325-018-0810-1 |
Keywords | Pharmacology (medical); General Medicine |
Public URL | https://hull-repository.worktribe.com/output/1116925 |
Publisher URL | https://link.springer.com/article/10.1007%2Fs12325-018-0810-1#enumeration |
Files
Review
(350 Kb)
PDF
Copyright Statement
© The Author(s) 2018<br />
<br />
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
You might also like
HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
(2023)
Journal Article
Modulatory properties of curcumin in cancer: A narrative review on the role of interferons
(2023)
Journal Article